XRP Whales Spark $500M Crypto Shakeout as Price Crashes – Will Ripple’s Token Soar Next?

XRP Today (Nov. 6, 2025): Ripple lands $500M at $40B valuation, pilots Mastercard stablecoin settlement, and ETF filings gather steam

XRP kicked off Thursday on a stronger footing as Ripple unveiled a mammoth funding round and a headline partnership with Mastercard—two catalysts that put institutional adoption back at the center of the XRP story.


Key takeaways

  • $500M strategic investment at a $40B valuation. Fortress Investment Group and Citadel Securities led Ripple’s new round, with participation from major funds—solidifying Ripple as one of crypto’s highest‑valued private companies. [1]
  • Mastercard pilot for RLUSD settlement. Ripple, Mastercard, WebBank, and Gemini are testing stablecoin settlement for credit card transactions using RLUSD on the XRP Ledger (XRPL). [2]
  • RLUSD passes $1B in circulation. Ripple’s USD‑backed stablecoin, introduced in Dec. 2024 under a New York trust charter model, crossed the $1B mark this week—fueling the payment pilot narrative. [3]
  • XRP ETF watch: Issuers—including Canary Capital—have amended S‑1 filings, and market watchers see a possible mid‑November window if the process continues uninterrupted. [4]
  • Legal overhang resolved. The SEC’s case against Ripple ended in August with a $125M penalty and limits on institutional sales—removing a key uncertainty for XRP. [5]

What happened today — and why it matters

1) Ripple’s $500M raise puts traditional finance on notice

Ripple confirmed a $500 million strategic investment led by Fortress Investment Group and Citadel Securities, valuing the company at $40 billion. The raise follows a year of expansion into stablecoins, custody, and prime brokerage—and it underlines deepening Wall Street participation in crypto infrastructure. [6]

Why it matters for XRP: a stronger corporate balance sheet and growing institutional relationships can translate into more payment corridors, deeper liquidity, and more consistent utility demand for XRP over time.

2) Mastercard x Ripple: RLUSD settlement pilot

At Ripple’s Swell 2025 event in New York, Mastercard, WebBank (issuer of the Gemini credit card), and Gemini joined Ripple to pilot settling fiat card transactions on a public blockchain using RLUSD (Ripple’s USD‑backed stablecoin) on the XRPL. If scaled, this would mark one of the first instances of a regulated U.S. bank testing stablecoin settlement on a public chain for card payments. [7]

Why it matters for XRP: XRPL sits at the heart of the pilot. Even as RLUSD handles dollar settlement, XRP underpins XRPL’s liquidity and payment mechanics, reinforcing its role in cross‑border and real‑time settlement networks.

3) RLUSD crosses $1B in circulation

RLUSD has surpassed $1 billion in outstanding supply less than a year after launch, signaling early traction with institutions and exchanges. That growth coincides with the Mastercard pilot and a broader institutional push highlighted at Swell. [8]


ETF watch: amended S‑1s, a potential mid‑November window

Filings for a spot XRP ETF have advanced. Canary Capital’s amended S‑1 is on the SEC’s docket, and industry reporting indicates that mid‑November is a plausible—but not guaranteed—window for the first XRP fund if the current process holds. Bottom line: filings are real; timelines remain conditional. [9]


Legal overhang: case closed in August

Regulatory clarity improved meaningfully when the SEC concluded its lawsuit against Ripple in August 2025, leaving a $125 million penalty and restrictions on certain institutional sales. For public‑exchange trading, Judge Torres’ earlier findings—that XRP itself and blind secondary‑market trades are not securities—stand, removing a major overhang for the asset. [10]


Market context & levels to watch

  • Momentum: Today’s price action reflects improving risk appetite after a choppy fortnight for crypto. For XRP, $2.35–$2.40 is the near‑term ceiling to clear for a sustained push; $2.20–$2.22 remains the first line of support.
  • Catalysts ahead:
    • Concrete updates from the Mastercard/WebBank pilot (scope, transaction volumes, expansion to new issuers). [11]
    • ETF decisions and effectiveness dates for amended S‑1s. [12]
    • Any new corridors or bank integrations unveiled post‑Swell.

By the numbers

  • Ripple valuation:$40B post‑raise. [13]
  • RLUSD in circulation:>$1B. [14]
  • XRP intraday range:$2.21 – $2.39 (today).
  • SEC case:Closed (Aug. 2025); $125M penalty stands. [15]

Editorial outlook (not investment advice)

With macro volatility still elevated, utility‑driven catalysts matter most for XRP. Ripple’s fresh capital and the Mastercard pilot speak directly to real‑world settlement—arguably the most credible path to durable demand. Near‑term price will likely track ETF headlines and pilot milestones; medium‑term trajectory hinges on how quickly enterprise payment volumes scale on XRPL.

RIPPLE CEO FINALLY SAID IT!!! MOST IMPORTANT XRP INTERVIEW EVER!!! (HISTORIC DAY FOR XRP!)

References

1. www.reuters.com, 2. www.coindesk.com, 3. www.coindesk.com, 4. www.sec.gov, 5. www.reuters.com, 6. www.reuters.com, 7. www.coindesk.com, 8. www.coindesk.com, 9. www.sec.gov, 10. www.reuters.com, 11. www.coindesk.com, 12. www.coindesk.com, 13. www.reuters.com, 14. www.coindesk.com, 15. www.reuters.com

Stock Market Today

  • Snap Stock Surges 18% on $400 Million Perplexity AI Deal
    November 6, 2025, 7:33 AM EST. Snap (SNAP) jumped 18% in pre-market after beating Q3 revenue estimates and announcing a $500 million stock buyback. Revenue rose to $1.51 billion, above expectations of $1.49B, while daily active users reached 477 million. The company inked a $400 million partnership with AI search startup Perplexity to embed its conversational search into Snapchat, starting in early 2026. The move diversifies revenue beyond ads, though the company warns about potential Q4 headwinds from Apple/Google age-verification changes and Australia's restrictions. Profitability improved, with net losses narrowing over 30% YoY and adjusted EBITDA of $182 million. Analysts' price targets and upside discussions remain mixed amid a year-to-date decline.
  • Is Elevance Health a Hidden Opportunity After a 24.5% Drop in 2025?
    November 6, 2025, 7:28 AM EST. Elevance Health has tumbled in 2025 amid policy shifts and broader healthcare-sector volatility, with a year-to-date drawdown and a longer 24.5% slide that has investors rethinking value. The piece weighs near- and long-term catalysts, noting that a high valuation score isn't translating into certainty as government program changes loom for managed care. The core takeaway is a rigorous DCF assessment, which, using current free cash flow of $3.6B and projected growth, yields an intrinsic value around $1,090.84 per share-roughly 71% above current prices, signaling undervaluation. Still, equity investors should monitor the PE ratio, competitive dynamics, and policy risk, which could affect how quickly this perceived bargain translates into realized gains.
  • Inflammation Biotech Evommune Starts NYSE Trading in $150M IPO
    November 6, 2025, 7:24 AM EST. Evommune is heading to the NYSE with a $150 million IPO to fund two clinical-stage assets. The Palo Alto biopharma is offering 9.3 million shares at $16 each, pricing in the $15-$17 range. Gross proceeds are $150 million, potentially rising by about $22.5 million if underwriters exercise their option for an additional 1.4 million shares. Trading under the ticker EVMN could begin today. The company plans to use the funds to advance two phase 2 programs, including EVO756, an oral MRGPRX2 antagonist being studied for CSU and atopic dermatitis (AD). Topline data for CSU from a phase 2 study showed 93% responses at four weeks. Data for AD topline in H2 2026. Evommune priced amid a broader biotech IPO backdrop as MapLight Therapeutics went public last week.
  • Arm Holdings Stock Surges on Q2 Beat, Strong AI Demand Lifts Outlook
    November 6, 2025, 7:22 AM EST. Arm Holdings (ARM) stock jumps about 5-6% in pre-market trading after reporting a Q2 beat that topped revenue and earnings estimates and issuing stronger Q3 guidance. The company posted revenue of $1.14 billion, up 34% year over year, and EPS of $0.22, exceeds consensus of $0.13. Arm also raised its quarterly revenue guide to about $1.23 billion versus the $1.10 billion expected. Royalty revenue reached a record $620 million, up 21%, led by data centers, automotive, and IoT, with hyperscalers like Google, Amazon, and Microsoft boosting Arm-based deployments. Licensing revenue rose 56% to $515 million. The AI infrastructure buildout underscores demand for Arm's energy-efficient designs, and management hints at potential in-house chip development beyond licensing.
  • Capital One Stock Prediction: Analysts See Up to 29% Upside by 2027 on Discover Acquisition
    November 6, 2025, 7:20 AM EST. Capital One (NYSE: COF) trades around $221 with an average target near $260, implying ~18% upside. Targets span $290 (high) and $210 (low), with a median near $258 and a mix of 14 Buys, 3 Outperforms, and 6 Holds. Growth projections call for revenue up about 19% annually through 2027, supported by operating margins near 48% and a forward multiple around 9.7x. A guided model points to ~$285/share by 2027, or about 29% total upside (12% annualized). The story centers on the Discover acquisition, expanded payments network, and stable credit trends amid solid consumer spending, though conviction remains modest and upside depends on continued earnings growth and credit stability.
Solana (SOL) Price Rollercoaster: From $250 Uptober High to $185 – Will It Rebound to $300?
Previous Story

Solana (SOL) Price Today, November 6, 2025: SOL steadies near $160 as fresh U.S. ETF inflows arrive and Grayscale waives GSOL fees

Vietnam’s Crypto Gold Rush: Binance, Bybit & Korean Custodian BDACS Supercharge Da Nang’s Digital Finance Hub
Next Story

Bitcoin price today (Nov. 6, 2025): BTC reclaims $103K as ETF outflows persist and ‘Strategy’ readies fresh buy-firepower

Go toTop